In February 2026, Recursion Pharmaceuticals reported fourth-quarter 2025 revenue of US$35.54 million, sharply higher than a year earlier, while its quarterly net loss narrowed to US$108.12 million and ...
After eight episodes of post-apocalypse insanity and plenty of irradiated creatures, Fallout wrapped up Season 2 with the season finale, “The Strip,” this week. Given that multiple characters are left ...
Warning: Full spoilers follow for Eternals. With Marvel’s Eternals now available on Disney+, whether you are watching it for the first time or the hundredth there is so much to take in about this MCU ...
Michael Boyle is an experienced financial professional with more than 10 years working with financial planning, derivatives, equities, fixed income, project management, and analytics. Jiwon Ma is a ...
Robert Kelly is managing director of XTS Energy LLC, and has more than three decades of experience as a business executive. He is a professor of economics and has raised more than $4.5 billion in ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results